Drawing for GENESCAPE

USPTO serial 97373762

GENESCAPE

Reviewed by CopyMark Law Group

Reg. 7072995Status 700Registered
Filing date
Status date
Registration date
Jun 6, 2023
Examiner
NGUYEN, CINDY EVANS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GENESCAPE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Keller

MICHAEL J. KELLER KELLER LIFE SCIENCE LAW, PA411 WALNUT STREETBOX 17975GREEN COVE SPRINGS, FL 32043

Goods and services

ClassDescriptionStatusFirst use
042Drug discovery services; scientific and technological services, namely scientific research and analysis in the field of target and drug optimization; scientific research screening of pharmaceuticals and biologics for therapeutic use including small molecules, proteins, RNA and DNA; scientific research screening using an entire genomes response to an administered compound or compounds; scientific research screening to find responses to therapeutic compounds by gene variants in a patient population; scientific research screening to find adverse events to therapeutic compounds and functional gene cluster mapping of interacting genes of an entire genomic response to administered compound; scientific research for medical purposes for identification of new clinical indications for known compounds; scientific research for medical purposes for comprehensive disease space mapping to understand how a compound fits into a disease space; and scientific research in the nature of comprehensive analysis of competitive drugs and derivatives thereof from a functional genome response to find new drug targetsACTIVEJun 6, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 6, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 21, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 16, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 15, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 15, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 15, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 15, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 8, 2023DOCKASSIGNED TO EXAMINER—
Apr 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 25, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance